oxybutynin has been researched along with Thoracic Neoplasms in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Thoracic Neoplasms: New abnormal growth of tissue in the THORAX.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garzón-Rodríguez, C | 1 |
Casals Merchan, M | 1 |
Calsina-Berna, A | 1 |
López-Rómboli, E | 1 |
Porta-Sales, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Preventive Application Of Lidocaine Patch In Adjunction To Intravenous Morphine Analgesia For Management Of Post-Thoracotomy Pain: Results Of A Randomized, Double Blind, Placebo Controlled Study[NCT02751619] | 90 participants (Actual) | Interventional | 2013-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for oxybutynin and Thoracic Neoplasms
Article | Year |
---|---|
Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results.
Topics: Anesthetics, Local; Breast Neoplasms; Cicatrix; Female; Follow-Up Studies; Humans; Lidocaine; Male; | 2013 |